Testing against a new strain, investigating allergic reactions and more — 5 COVID-19 vaccine updates

Here are five updates on the COVID-19 vaccine over the past week:

Advertisement

Johnson and Johnson is expected to release data on its vaccine in early January, according to a Dec. 22 report from FOX 31.

Moderna’s COVID-19 vaccine received emergency use authorization from the FDA Dec. 18, making it the second vaccine approved in the U.S.

The FDA is investigating reports of allergic reactions to the Pfizer-BioNTech COVID-19 vaccine.

Pfizer and Moderna are testing their COVID-19 vaccines against a mutated strain of the coronavirus that first appeared in England.

Hospital pharmacists discovered Dec. 16 that some vials of Pfizer’s COVID-19 vaccines that are supposed to hold five doses actually contain six or seven.

More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.